Reposify released its Pharmaceutical Industry Attack Surface Exposures Report examining the security posture of the world’s leading pharmaceutical companies. The report assessed the prevalence of exposures of services, sensitive platforms, unpatched CVEs and other security issues. In 70% of pharmaceutical M&A deals in 2020, the newly acquired subsidiary had a negative impact on the security of the parent company ‘ adding tens, in some cases, hundreds of sensitive exposed services. The safety of clinical research, manufacturing and supply chains have never been so important to humanity, and yet, pharmaceutical companies remain ill prepared.
Source: https://www.helpnetsecurity.com/2021/08/03/pharmaceutical-companies-exposed-database/